ZIMV

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About ZimVie Inc

CEO
Employees
0
Headquarters

News

ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
Mar 23, 2023 12:30pm

Publication highlights Puros Cancellous Particulate Allograft’s collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to competitive freeze-dried allograft solutions Publication highlights Puros Cancellous Particulate Allograft’s collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to competitive freeze-dried allograft solutions


Source:GlobeNewswire
ZimVie’s Exclusive Puros Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants
Mar 23, 2023 12:30pm

Publication highlights Puros Cancellous Particulate Allograft’s collagen microstructure and greater surface area for significantly higher mesenchymal stromal cellular (hBMSC) response compared to competitive freeze-dried allograft solutions WESTMINSTER, Colo., March 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today


Source:Wallstreet:Online
ZimVie adds 15% most in four months on favorable coverage decisions
Mar 15, 2023 19:04pm

Shares of the MedTech company ZimVie (ZIMV) climbed ~15%, marking the highest intraday gain since November after announcing that two healthcare payers have issued positive medical…


Source:Seeking Alpha
Early Moves to Watch: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD -0.09%), ZimVie Inc. (NASDAQ:ZIMV -7.99%)
Mar 08, 2023 12:28pm

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) with the stream of -0.09% also noticed, India ZimVie Inc. (NASDAQ:ZIMV) encountered a rapid change of -7.99% in the last hour of Tuesday’s trading session. On … The post Early Moves to Watch: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD -0.09%), ZimVie Inc. (NASDAQ:ZIMV -7.99%) appeared first on Stocks Equity .


Source:Stock Equity
ZimVie Inc. (ZIMV)’s Stock Price Falls Due To Weak Fundamental Momentum
Mar 06, 2023 16:00pm

ZimVie Inc. (NASDAQ:ZIMV) has seen 2.04 million shares traded in the last trading session. The company, currently valued at $151.27M, closed the last trade at $6.22 per share which meant it gained $0.42 on the day or 7.24% during that session. The ZIMV stock price is -365.27% off its 52-week high price of $28.94 and … ZimVie Inc. (ZIMV)’s Stock Price Falls Due To Weak Fundamental Momentum Read More »


Source:Marketing Sentinel
Have you been able to find a good deal on ZimVie Inc.’s shares?
Mar 06, 2023 13:40pm

As of Friday, ZimVie Inc.’s (NASDAQ:ZIMV) stock closed at $6.22, up from $5.80 the previous day. While ZimVie Inc. has overperformed by 7.24%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ZIMV fell by -74.41%, with highs and lows ranging from $28.94 to $5.05, whereas the […]


Source:US Post News
Why ZimVie Stock Was Plummeting on Thursday
Mar 02, 2023 21:07pm

The specialty healthcare devices and tech purveyor disappointed with both fourth-quarter figures and full-year guidance.


Source:The Motley Fool
How is ZIMV’s stock performing after recent trades?
Mar 02, 2023 17:00pm

In the current trading session, ZimVie Inc.’s (ZIMV) stock is trading at the price of $6.20, a fall of -40.73% over last night’s close. So, the stock is trading at a price that is -78.58% less than its 52-week high of $28.94 and -7.05% better than its 52-week low of $6.67. Based on the past […]


Source:US Post News
ZimVie crashes 37% to hit a post IPO-low after Q4 earnings
Mar 02, 2023 16:06pm

ZimVie (ZIMV) lost ~37% on Thursday to reach the lowest level since its IPO after reporting lower-than-expected Q4 2022 results and issuing underwhelming guidance. Read the full story here.


Source:Seeking Alpha
OncoSec, BioRestorative top healthcare gainers; ZimVie, Cano among losers
Mar 02, 2023 15:00pm

OncoSec Medical (ONCS) +44%. BioRestorative Therapies BRTX +32%. ZimVie (ZIMV) -45%. Cano Health (CANO) -23%.


Source:Seeking Alpha
ZimVie (ZIMV) Q4 2022 Earnings Call Transcript
Mar 02, 2023 01:30am

ZIMV earnings call for the period ending December 31, 2022.


Source:The Motley Fool
ZimVie Inc. (ZIMV) Q4 2022 Earnings Call Transcript
Mar 02, 2023 00:47am

ZimVie Inc. (NASDAQ:NASDAQ:ZIMV) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ETCompany ParticipantsMarissa Bych - Investor RelationsVafa Jamali - President & Chief Executive…


Source:Seeking Alpha
ZimVie Non-GAAP EPS of $0.16 misses by $0.05, revenue of $229.12M misses by $7.88M, guidance below consensus
Mar 01, 2023 21:42pm

ZimVie press release (ZIMV): Q4 Non-GAAP EPS of $0.16 misses by $0.05.Revenue of $229.12M (-12.4% Y/Y) misses by $7.88M.FY23 expected revenue of $825M - $850M, vs


Source:Seeking Alpha
ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 01, 2023 21:05pm

WESTMINSTER, Colo., March 01, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported financial results for the fourth quarter and full year ended December 31, 2022. Management will host a corresponding conference call today, March 1, 2023, at 4:30 p.m. Eastern Time.


Source:GlobeNewswire
ZimVie Announces Launch of the RealGUIDE CAD and FULL SUITE Software Modules
Feb 23, 2023 13:30pm

Two innovations enhancing ZimVie’s digital dentistry platform WESTMINSTER, Colo., Feb. 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the RealGUIDE CAD and FULL SUITE modules, the latest innovations within ZimVie’s digital dentistry software platform. The CAD (computer-aided design) module


Source:Wallstreet:Online
ZimVie to Report Fourth Quarter and Full Year 2022 Financial Results on March 1, 2023
Feb 13, 2023 21:10pm

WESTMINSTER, Colo., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full year 2022 after market close on Wednesday, March 1, 2023. Management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.


Source:GlobeNewswire
Mind-blowing stocks: ZimVie Inc. (NASDAQ:ZIMV -0.38%), 22nd Century Group, Inc. (NASDAQ:XXII 2.91%)
Feb 08, 2023 12:01pm

ZIMV has seen its SMA50 which is now 14.43%. In looking the SMA 200 we see that the stock has seen a -26.80%. XXII has seen its SMA50 which is … The post Mind-blowing stocks: ZimVie Inc. (NASDAQ:ZIMV -0.38%), 22nd Century Group, Inc. (NASDAQ:XXII 2.91%) appeared first on Stocks Equity .


Source:Stock Equity
ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C
Jan 30, 2023 21:10pm

Milestone aligns with ten-year anniversary of Mobi-C FDA approval for treatment of one and two levels of the cervical spine WESTMINSTER, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 200,000 Mobi-C Cervical Discs have been implanted worldwide. This includes patients treated in over


Source:Wallstreet:Online
ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®
Jan 30, 2023 21:10pm

Milestone aligns with ten-year anniversary of Mobi-C FDA approval for treatment of one and two levels of the cervical spine Milestone aligns with ten-year anniversary of Mobi-C FDA approval for treatment of one and two levels of the cervical spine


Source:GlobeNewswire